Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4114 Target Snapshot

Beta-lactamase · SINGLE PROTEIN · Staphylococcus aureus

183Compounds
46Assays
4Approved Drugs
148.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P00807. Use UniProt P00807 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P00807 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Beta-lactamase as ChEMBL target CHEMBL4114, mapped to UniProt P00807. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Beta-lactamase
SINGLE PROTEIN · Staphylococcus aureus
As of 2026-09-13
ChEMBL target ID
CHEMBL4114
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P00807
Beta-lactamase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Beta-lactamase is the right protein anchor across sources, using UniProt P00807 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelBeta-lactamase
UniProt AccessionP00807
Component TypeProtein
Sequence Length281 aa

Beta-lactamase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Beta-lactamase, mapped to UniProt P00807. Sequence length is 281 aa.

Mapped IDP00807
Review nameBeta-lactamase
OrganismStaphylococcus aureus
Clinical Profile

Clinical Phase Distribution

4
Approved
Assay Mix

Activity Type Distribution

IC50148.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL294608 9.0 IC50 1.0 Preclinical
CHEMBL294203 8.4 IC50 4.0 Preclinical
CHEMBL292093 7.81 IC50 15.4 Preclinical
CHEMBL303053 7.58 IC50 26.0 Preclinical
CHEMBL268919 7.52 IC50 30.0 Preclinical
CHEMBL777 7.1 IC50 80.0 Approved
CHEMBL353613 7.0 IC50 100.0 Preclinical
CHEMBL305361 6.98 IC50 105.0 Preclinical
CHEMBL61762 6.75 IC50 180.0 Preclinical
CHEMBL64793 6.71 IC50 196.0 Preclinical
Distribution

pChEMBL Value Distribution

11
5.0
10
5.5
11
6.0
11
6.5
5
7.0
3
7.5
1
8.0
0
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

TAZOBACTAM SODIUM
CHEMBL1439
Approved 1993
TAZOBACTAM
CHEMBL404
Approved 1993
CLAVULANIC ACID
CHEMBL777
Approved 1984
Assay Landscape

Assay Landscape

46
Total Assays
55
Tested Compounds
2
Assay Types
Binding — 42 assays, 55 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 42 55 5.8
Functional — 4 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 4 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine